The African Medicines Regulatory Harmonization (AMRH) programme has concluded plans to host the first Heads of Medicines Registration and Marketing Authorization Forum in Nairobi, Kenya, reports ITREALMS.
Led by the African Union Development Agency-NEPAD, the AMRH, ITREALMS also gathered, has been instrumental in enhancing regulatory capacities to ensure the safety and accessibility of medicines across Africa. With the global market for counterfeit medicines valued at US$65–200 billion annually, prompt action is essential.
The meeting aims to establish a collaborative platform among African National Regulatory Authorities (NRAs), facilitating information exchange and the development of continental recommendations for registration and marketing authorization. On the last day, the first leaders of the continental forum will be elected.
They will oversee the coordination of all 55 AU Member States in sharing information and adopting continental scientific recommendations.
Additionally, the Forum's leadership will support countries in implementing these recommendations effectively, facilitating the efficient functioning of continental product approval processes.
Ensuring that medicine for African citizens is of high quality, efficacious and easily accessible. Key objectives of the meeting include:Electing the leadership of the Continental Forum.
Discussing and adopting the Forum’s Terms of Reference.
Agreeing on mechanisms for translating continental recommendations to national registrations/Marketing Authorization (MA).
Discussing and adopting the Forum’s Terms of Reference.
Agreeing on mechanisms for translating continental recommendations to national registrations/Marketing Authorization (MA).
No comments:
Post a Comment